Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Interim data on the effects of GTI-2040 and capecitabine in advanced renal cell cancer

Jan. 20, 2004

Phase Ib trial evaluates WX-UK1 in head and neck cancer patients

Jan. 19, 2004

Novel protein kinase inhibitors for cancer and neurological disorders

Jan. 19, 2004

Morphotek and NCI sign agreement to develop antibodies for the treatment of various cancers

Jan. 19, 2004

Dosing commenced in phase II adult AML trial of clofarabine

Jan. 16, 2004

SB-715992 enters broad phase II program for cancer

Jan. 16, 2004

Novel class of farnesyltransferase inhibitors synthesized by Abbott

Jan. 15, 2004

MPI-176716 produces tumor regression in animal models of ovarian cancer

Jan. 15, 2004

BioStratum and Novo Nordisk to develop antibodies to laminin-5 for cancer

Jan. 15, 2004

Eloxatin approved for first-line treatment of advanced colorectal cancer

Jan. 15, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...